Acamprosate CA 333MG tab national cmop

Cancelled Solicitation Posted

Solicitation number
36C77026Q0092
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 is soliciting quotations for Acamprosate Calcium 333mg enteric-coated tablets in 180-count bottles under RFQ 36C77026Q0092. Offerors must be registered in SAM.gov, maintain valid state wholesale distributor licenses, and provide Trade Agreements Act (TAA) certificates demonstrating product compliance with FAR Parts 52.225-5 and 52.225-6. Key contract requirements include bar code labeling compliant with GS1-128 or HIBCC standards, minimum 12-month expiration dates from delivery, Drug Supply Chain Security Act (DSCSA) compliance with appropriate transaction history documentation, and submission of pricing in Excel format with country of manufacture information. The Government will evaluate proposals based on the offerors' ability to meet these regulatory and compliance requirements, product availability confirmation 24 hours prior to purchase order issuance, and adherence to the specified National Drug Code (NDC 68462-0435-18) unless no TAA-compliant product is available. The solicitation was issued on February 25, 2026, with an offer due date of March 4, 2026, at 4:00 p.m. CDT, and inquiries should be directed to Sarah Fry at sarah.fry2@va.gov or 913-758-9935.

This is an unrestricted solicitation with no set-asides, and no incumbent contractor is identified. The total requirement spans 5,496 bottles distributed across six VA Consolidated Mail Outpatient Pharmacy (CMOP) locations: Chelmsford, Massachusetts (384 bottles), Tucson, Arizona (1,200 bottles), Lancaster, Texas (1,200 bottles), Murfreesboro, Tennessee (432 bottles), Hines, Illinois (1,080 bottles), and Charleston, South Carolina (1,200 bottles). First delivery must occur within 10 days of award, with subsequent monthly deliveries required over three months thereafter, and all shipments are FOB Destination with payment via Electronic Funds Transfer upon acceptance and delivery. While no specific award value is disclosed in the solicitation documents, the pricing schedule must be completed and submitted with all supporting documentation. Performance will take place at the six designated VA locations throughout the United States.

Notice text

RFQ 36C77026Q0092

Pricing excel spreadsheet attached.

52.225-6 TRADE AGREEMENTS CERTIFICATE attached.

Files

File Type Posted
S02_RFQ_36C77026Q0092.pdf PDF
S02_Pricing Schedule_Q0092.xlsx XLSX spreadsheet
S02_RFQ_36C77026Q0092.pdf PDF
52.225-6 TRADE AGREEMENTS CERTIFICATE.docx DOCX document

Notice history

Notice Type Posted
This notice Latest solicitation Solicitation
Acamprosate CA 333MG tab national cmop Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sacubitril/Valsartan Tablets (VA-27-00014055) NAICS 325412 National Acquisition Center No set-aside
6505--Ramipril Capsules RFP NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors